Literature DB >> 34050182

Enhancing CRISPR-Cas9 gRNA efficiency prediction by data integration and deep learning.

Xi Xiang1,2,3,4, Giulia I Corsi5, Christian Anthon5, Kunli Qu1,6, Xiaoguang Pan1, Xue Liang1,6, Peng Han1,6, Zhanying Dong1, Lijun Liu1, Jiayan Zhong7, Tao Ma7, Jinbao Wang7, Xiuqing Zhang3, Hui Jiang7, Fengping Xu1,3, Xin Liu3, Xun Xu3,8, Jian Wang3, Huanming Yang3,9, Lars Bolund1,3,4, George M Church10, Lin Lin1,4,11, Jan Gorodkin12, Yonglun Luo13,14,15,16.   

Abstract

The design of CRISPR gRNAs requires accurate on-target efficiency predictions, which demand high-quality gRNA activity data and efficient modeling. To advance, we here report on the generation of on-target gRNA activity data for 10,592 SpCas9 gRNAs. Integrating these with complementary published data, we train a deep learning model, CRISPRon, on 23,902 gRNAs. Compared to existing tools, CRISPRon exhibits significantly higher prediction performances on four test datasets not overlapping with training data used for the development of these tools. Furthermore, we present an interactive gRNA design webserver based on the CRISPRon standalone software, both available via https://rth.dk/resources/crispr/ . CRISPRon advances CRISPR applications by providing more accurate gRNA efficiency predictions than the existing tools.

Entities:  

Year:  2021        PMID: 34050182     DOI: 10.1038/s41467-021-23576-0

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  14 in total

Review 1.  High-throughput methods for genome editing: the more the better.

Authors:  Yong Huang; Meiqi Shang; Tingting Liu; Kejian Wang
Journal:  Plant Physiol       Date:  2022-03-28       Impact factor: 8.340

Review 2.  Enzyme-free targeted DNA demethylation using CRISPR-dCas9-based steric hindrance to identify DNA methylation marks causal to altered gene expression.

Authors:  Daniel M Sapozhnikov; Moshe Szyf
Journal:  Nat Protoc       Date:  2022-10-07       Impact factor: 17.021

3.  CRISPR/Cas9 gRNA activity depends on free energy changes and on the target PAM context.

Authors:  Giulia I Corsi; Kunli Qu; Ferhat Alkan; Xiaoguang Pan; Yonglun Luo; Jan Gorodkin
Journal:  Nat Commun       Date:  2022-05-30       Impact factor: 17.694

4.  Massively targeted evaluation of therapeutic CRISPR off-targets in cells.

Authors:  Xiaoguang Pan; Kunli Qu; Hao Yuan; Xi Xiang; Christian Anthon; Liubov Pashkova; Xue Liang; Peng Han; Giulia I Corsi; Fengping Xu; Ping Liu; Jiayan Zhong; Yan Zhou; Tao Ma; Hui Jiang; Junnian Liu; Jian Wang; Niels Jessen; Lars Bolund; Huanming Yang; Xun Xu; George M Church; Jan Gorodkin; Lin Lin; Yonglun Luo
Journal:  Nat Commun       Date:  2022-07-13       Impact factor: 17.694

5.  CRISPR-Cas9 gRNA efficiency prediction: an overview of predictive tools and the role of deep learning.

Authors:  Vasileios Konstantakos; Anastasios Nentidis; Anastasia Krithara; Georgios Paliouras
Journal:  Nucleic Acids Res       Date:  2022-04-22       Impact factor: 19.160

6.  Evaluation of CRISPR gene-editing tools in zebrafish.

Authors:  José M Uribe-Salazar; Gulhan Kaya; Aadithya Sekar; KaeChandra Weyenberg; Cole Ingamells; Megan Y Dennis
Journal:  BMC Genomics       Date:  2022-01-06       Impact factor: 4.547

Review 7.  How to Find the Right RNA-Sensing CRISPR-Cas System for an In Vitro Application.

Authors:  Escarlet Díaz-Galicia; Raik Grünberg; Stefan T Arold
Journal:  Biosensors (Basel)       Date:  2022-01-19

8.  Genome-wide functional screens enable the prediction of high activity CRISPR-Cas9 and -Cas12a guides in Yarrowia lipolytica.

Authors:  Dipankar Baisya; Adithya Ramesh; Cory Schwartz; Stefano Lonardi; Ian Wheeldon
Journal:  Nat Commun       Date:  2022-02-17       Impact factor: 14.919

Review 9.  A Brief Overview of Global Trends in MSC-Based Cell Therapy.

Authors:  Dragomirka Jovic; Yingjia Yu; Dan Wang; Kuixing Wang; Hanbo Li; Fengping Xu; Chenglong Liu; Junnian Liu; Yonglun Luo
Journal:  Stem Cell Rev Rep       Date:  2022-03-28       Impact factor: 6.692

Review 10.  CRISPR/Cas9 and next generation sequencing in the personalized treatment of Cancer.

Authors:  Sushmaa Chandralekha Selvakumar; K Auxzilia Preethi; Kehinde Ross; Deusdedit Tusubira; Mohd Wajid Ali Khan; Panagal Mani; Tentu Nageswara Rao; Durairaj Sekar
Journal:  Mol Cancer       Date:  2022-03-24       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.